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ylated Sm.
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Inter-molecular interactions between two smooth muscle myosin heads have
been observed using chemical cross linking and visualized by electron micros-
copy. In order to probe the nature of the phosphorylation-dependent head-head
interactions, we performed Hydrogen-Deuterium exchange electrospray ioni-
zation mass spectrometry (HDX-MS) on phosphorylated and unphosphorylated
smooth muscle heavy mero myosin (HMM) from chicken gizzard. HDX rates
are determined by solvent accesibility and the strength of hydrogen bonding
and thus are a good fingerprint of intra- and intermolecular structural changes.
The observed decrease in deuterium uptake upon phosphorylation in the coiled-
coil and the hinge region of the heavy chain (residues 864-877), is consistent
with the unraveling of the myosin dimer at the hinge. Unexpectedly, we have
observed phosphorylation dependent changes in the regulatory light chain
(RLC 58-69), which are not implicated in the RLC-RLC or RLC-heavy chain
interface. No changes were observed for N-terminal region of RLC that was
postulated to undergo major secondary structure changes, or in the heavy chain
actin binding site (residues 397-437) , or any of the residues that form the head-
head interface in the EMmodel of Wendt & Taylor. This latter finding indicates
that the interaction between the heads is probably transient in solution, or in the
unlikely case, interacting heads constitute a very small fraction of total protein.
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Smooth muscle is distributed in many organs, and plays a critical role in main-
taining blood pressure in vasculature and airflow in airway and malfunction of
the smooth muscle causes severe health problems. Smooth muscle contraction
is primarily regulated by myosin light chain (MLC) phosphorylation, which is
regulated by both Ca2þ dependent and Ca2þ independent pathways. Recent
studies have revealed that MLC phosphatase (MLCP) plays a key role in the
latter mechanism. MLCP activity is regulated by the phosphorylation of
MYPT1, a myosin binding regulatory subunit of MLCP, and CPI-17,
a MLCP specific inhibitor protein. Here we found novel signaling mechanism
of controlling smooth muscle contraction induced by agonists. We found that
agonist stimulation significantly activates Rac1 activity in smooth muscle,
and the inhibition of Rac markedly decreases agonist induced force of arterial
smooth muscle. Moreover, introduction of active Rac1 activates smooth muscle
contraction, while dominant-negative Rac1 attenuates the agonist-induced con-
traction. Rac1 dependent change in contraction is accompanied by the change
in MLC phosphorylation, MYPT1 phosphorylation and CPI-17 hosphorylation.
Rac inhibitors activatedMLCP activity, but not MLCK activity, suggesting that
Rac1 dependent change in MLC phosphorylation is due to the change in MLCP
activity. Rac inhibitors did not change RhoA and ROCK activities, unlike
RhoA pathway. Interestingly, Rac1 inhibition induced the change in
MYPT1/CPI-17 phosphatase activity. The result suggests that Rac1 dependent
change in MYPT1/CPI-17 phosphorylation is due to the change in the phospha-
tase activity rather than the kinase activites that phopshorylate MYPT1 and
CPI-17 such as ROCK. These results suggest that agonist induced change in
MLCP activity in smooth muscle is concertedly regulated by RhoA pathway
that modulates ROCK and Rac1 pathway that regulates MYPT1/CPI-17
phosphatases.
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Vertebrate smooth muscle contraction is regulated by phosphorylation of the
myosin regulatory light chains. EM studies of smooth muscle myosin mole-
cules suggest that in the dephosphorylated state, activity is switched off by
asymmetric interactions between the two myosin heads, in which the
‘‘blocked’’ head is thought to be unable to bind to actin, while the ‘‘free’’head has its ATPase activity inhibited. Comparative sequence analysis and mo-
lecular modeling suggest that the head interaction may be stabilized by charge
attraction between D748 in the converter domain of the free head and K368 of
the blocked head, and between R406 or K416 of the blocked head and E169 of
the free head (Jung et al., MBC, 2008). To test these possibilities, we investi-
gated the structure of expressed smooth muscle myosin and heavy meromyosin
in which the charges at some of these sites was neutralized or reversed. While
most of the mutants showed no obvious change in structure compared with wild
type, HMM with charge reversal at both 368 and 406 showed fewer molecules
with interacting heads when observed by metal shadowing. This was supported
by a decrease in sedimentation coefficient (determined by analytical ultracen-
trifugation) and an increase in actin-activated ATPase activity of the mutant.
Whole myosin with the same mutations formed filaments more readily than
wild type, also consistent with these results. These observations suggest that
charge interactions involving K368 and R406 play a role in stabilizing the
head-head interaction of the inactive state. Interestingly, mutation of R403 in
cardiac myosin (R406 in smooth muscle) increases motor activity of myosin
and causes familial hypertrophic cardiomyopathy. Our results suggest that
this could be in part a result of changes in head interaction.
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We are using fluorescence microscopy to characterize the interaction of single
active MLCK molecules with smooth muscle myosin (SMM) filaments and
acto-SMM bundles in an in vitro: model system to determine the mechanism
by which MLCK phosphorylates SMM. Since ATP is required for the SMM
ATPase and the MLCK kinase activity, this requires unphosphorylated SMM
filaments that are stable in the presence of ATP, a condition that normally
causes disassembly. We have prepared and characterized modified SMM fila-
ments for this study. They are 1) covalently labeled with NHS-Rhodamine
for ease of imaging, 2) lightly cross-linked with EDC on the heavy chain so
they are stable to ATP-induced disassembly, 3) similar to native SMM fila-
ments in length, 4) fully regulated by phosphorylation measured by acto-
SMM ATPase activity, and the ability to move actin in an in vitro motility as-
say, and 5) able to dissociate from actin in an [ATP]-dependent manner. Inter-
estingly, these modified SMM filaments are capable of bundling actin filaments
in the presence of ATP, calmodulin (CaM), and Ca2þ; conditions that are suf-
ficient for MLCK to phosphorylate SMM. SMMfilaments preferentially bind to
actin bundles rather than single actin filaments, and as ATP is titrated into
a preparation of acto-SMM bundles, they dissociate leaving short actin fila-
ments which are predominantly bound to SMM filaments. We have imaged
the interaction of single quantum dot-labeled MLCK (QD-MLCK) molecules
with these SMMfilaments and acto-SMM bundles using total internal reflection
fluorescence (TIRF) microscopy to visualize single QD-MLCK. We observed
QD-MLCK colocalizing with SMM filaments and acto-SMM bundles and will
characterize the QD-MLCK interaction with both proteins in the presence of
ATP before and after activation of MLCK by Ca2þ-CaM.
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Smooth muscle (SM) hyper-contractility is central to the pathophysiology of
several diseases, including asthma. Inflammatory cells and/or their products
may alter the expression of contractile proteins, thereby enhancing SM me-
chanics. The goal of the current study was to characterize the maximum un-
loaded shortening velocity (Vmax), stress (force/cross sectional area), and
contractile protein expression of Brown Norway (BN) rat airway SM in the
presence of activated CD4þ T cells. T cells from OVA-sensitized BN rats
were co-cultured with tracheal rings for 24h. The SM strips were then mounted
in a mechanical testing apparatus, equilibrated and supramaximally stimulated
with methacholine. A significant increase in Vmax (mean5S.E.) (0.1550.01 l/s
for control, 0.2950.02 l/s for sensitized, p=0.0012) was observed whereas no
significant changes in stress (84.5513.9 kPa for control, 107.854.8 kPa for
sensitized) were seen. Western blot analysis showed that levels of the (þ)insert
myosin heavy chain isoform and myosin light chain kinase (MLCK) were sig-
nificantly increased. To determine whether contact between T cells and SM
cells is required for this enhanced contractility, CD4þT cells were placed in
the upper chamber of a transwell, separated by a membrane from the muscle
